EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis

Faidra Laskou, Victoria Konzett, Josef S Smolen, Christopher J Edwards, Daniel Aletaha, Désirée van der Heijde, Kevin L Winthrop, Tsutomu Takeuchi, Roberto Caporali, Patrick Verschueren, Janet E Pope, Kimme Hyrich und 6 weitere

Annals of the Rheumatic Diseases · 2026-06 · 85 (6) · 1055-1072

DOI: 10.1016/j.ard.2026.02.024 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of the Rheumatic Diseases, 2026-06. Verfasst von Faidra Laskou und 17 weiteren Autor:innen. Beteiligte Einrichtung: MRC Lifecourse Epidemiology Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: f.laskou@s…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Biological Products, Synthetic Drugs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EULAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsBiological ProductsSynthetic DrugsHumansOpportunistic InfectionsPractice Guidelines as Topic

Substanzen

Antirheumatic AgentsBiological ProductsSynthetic Drugs

Autor:innen und Institutionen

  • MRC Lifecourse Epidemiology Centre Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: f.laskou@soton.ac.uk.
  • Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
  • NIHR Southampton Clinical Research Facility, University Hospital Southampton, Southampton, UK.
  • Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • School of Public Health, Oregon Health & Science University, Portland, OR, USA.
  • Department of Rheumatology and Applied Immunology/Clinical Immunology, Saitama Medical University, Moroyama-machi, Iruma, Saitama, Japan.

Förderung

  • EULAR

Zitieren

APA

Laskou, F., Konzett, V., Smolen, J. S., Edwards, C. J., Aletaha, D., van der Heijde, D., Winthrop, K. L., Takeuchi, T., Caporali, R., Verschueren, P., Pope, J. E., Hyrich, K., de Souza, S., Stamm, T. A., Primdahl, J., Schoones, J. W., Landewé, R. B., & Kerschbaumer, A. (2026). Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases, 85(6), 1055-1072. https://doi.org/10.1016/j.ard.2026.02.024

Vancouver

Laskou F, Konzett V, Smolen JS, Edwards CJ, Aletaha D, van der Heijde D, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2026;85(6):1055-1072. doi:10.1016/j.ard.2026.02.024

BibTeX
@article{Laskou2026,
  author = {Laskou, Faidra and Konzett, Victoria and Smolen, Josef S and Edwards, Christopher J and Aletaha, Daniel and van der Heijde, Désirée and Winthrop, Kevin L and Takeuchi, Tsutomu and Caporali, Roberto and Verschueren, Patrick and Pope, Janet E and Hyrich, Kimme and de Souza, Savia and Stamm, Tanja A and Primdahl, Jette and Schoones, Jan W and Landewé, Robert Bm and Kerschbaumer, Andreas},
  title = {Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {6},
  pages = {1055--1072},
  doi = {10.1016/j.ard.2026.02.024}
}
Kostenlos starten →